118 related articles for article (PubMed ID: 36811015)
21. Review: prospects for the use of extracts and polysaccharides from marine algae to prevent and treat the diseases caused by Helicobacter pylori.
Besednova NN; Zaporozhets TS; Somova LM; Kuznetsova TA
Helicobacter; 2015 Apr; 20(2):89-97. PubMed ID: 25660579
[TBL] [Abstract][Full Text] [Related]
22. Extracellular Polymeric Substances: Still Promising Antivirals.
Bello-Morales R; Andreu S; Ruiz-Carpio V; Ripa I; López-Guerrero JA
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746808
[TBL] [Abstract][Full Text] [Related]
23. A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections.
Pradhan B; Nayak R; Patra S; Bhuyan PP; Behera PK; Mandal AK; Behera C; Ki JS; Adhikary SP; MubarakAli D; Jena M
Carbohydr Polym; 2022 Sep; 291():119551. PubMed ID: 35698330
[TBL] [Abstract][Full Text] [Related]
24. Antiviral Activities of Algal-Based Sulfated Polysaccharides.
Panggabean JA; Adiguna SP; Rahmawati SI; Ahmadi P; Zainuddin EN; Bayu A; Putra MY
Molecules; 2022 Feb; 27(4):. PubMed ID: 35208968
[TBL] [Abstract][Full Text] [Related]
25. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
Front Immunol; 2021; 12():801799. PubMed ID: 35222355
[TBL] [Abstract][Full Text] [Related]
26. Seaweed-Derived Sulfated Polysaccharides; The New Age Chemopreventives: A Comprehensive Review.
Bhuyan PP; Nayak R; Patra S; Abdulabbas HS; Jena M; Pradhan B
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765670
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
Dinda B; Dinda S; Dinda M
Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
[TBL] [Abstract][Full Text] [Related]
28. An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment.
Fuzimoto AD
J Integr Med; 2021 Sep; 19(5):375-388. PubMed ID: 34479848
[TBL] [Abstract][Full Text] [Related]
29. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
30. Promising role of defensins peptides as therapeutics to combat against viral infection.
Solanki SS; Singh P; Kashyap P; Sansi MS; Ali SA
Microb Pathog; 2021 Jun; 155():104930. PubMed ID: 33933603
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
Kim CH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
[TBL] [Abstract][Full Text] [Related]
32. Sulfated derivatives of Escherichia coli K5 polysaccharides as modulators of fibroblast growth factor signaling.
Borgenström M; Jalkanen M; Salmivirta M
J Biol Chem; 2003 Dec; 278(50):49882-9. PubMed ID: 14514688
[TBL] [Abstract][Full Text] [Related]
33. A Sulfated Abalone Polysaccharide Inhibited SARS-CoV-2 Infection of Vero E6 Cells In Vitro.
Sun J; Song S; Ai C; Zhu B; Yang J
Foods; 2022 Sep; 11(18):. PubMed ID: 36140993
[TBL] [Abstract][Full Text] [Related]
34. Polysaccharides and Their Derivatives as Potential Antiviral Molecules.
Claus-Desbonnet H; Nikly E; Nalbantova V; Karcheva-Bahchevanska D; Ivanova S; Pierre G; Benbassat N; Katsarov P; Michaud P; Lukova P; Delattre C
Viruses; 2022 Feb; 14(2):. PubMed ID: 35216019
[TBL] [Abstract][Full Text] [Related]
35. Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta.
Fröba M; Große M; Setz C; Rauch P; Auth J; Spanaus L; Münch J; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Prieschl-Grassauer E; Grassauer A; Schubert U
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947999
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic developments for SARS-CoV-2 infection-Molecular mechanisms of action of antivirals and strategies for mitigating resistance in emerging variants in clinical practice.
Săndulescu O; Apostolescu CG; Preoțescu LL; Streinu-Cercel A; Săndulescu M
Front Microbiol; 2023; 14():1132501. PubMed ID: 36937282
[TBL] [Abstract][Full Text] [Related]
37. Is copper beneficial for COVID-19 patients?
Raha S; Mallick R; Basak S; Duttaroy AK
Med Hypotheses; 2020 Sep; 142():109814. PubMed ID: 32388476
[TBL] [Abstract][Full Text] [Related]
38. Profiling carbohydrate-receptor interaction with recombinant innate immunity receptor-Fc fusion proteins.
Hsu TL; Cheng SC; Yang WB; Chin SW; Chen BH; Huang MT; Hsieh SL; Wong CH
J Biol Chem; 2009 Dec; 284(50):34479-89. PubMed ID: 19837675
[TBL] [Abstract][Full Text] [Related]
39. [Glycosylation, glycan receptors recognition of SARS-CoV-2 and discoveries of glycan inhibitors against SARS-CoV-2].
Yu W; Xu Y; Li J; Li Z; Wang Q; DU Y
Sheng Wu Gong Cheng Xue Bao; 2022 Sep; 38(9):3157-3172. PubMed ID: 36151791
[TBL] [Abstract][Full Text] [Related]
40. Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19.
Alhazmi HA; Najmi A; Javed SA; Sultana S; Al Bratty M; Makeen HA; Meraya AM; Ahsan W; Mohan S; Taha MME; Khalid A
Front Immunol; 2021; 12():637553. PubMed ID: 34054806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
